Teleflex Inc (TFX) stock
TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30315% above fair value
$157.10+2.00 (+1.29%)
Close on Nov 16, 2026Market cap $6.66BP/E –Yield 0.87%
Teleflex r&d expenses
Research and development expenses are spending on new products and technology.
Teleflex's R&D Expenses for the twelve months ending Jun 30, 2026 was $159.36M, up 18.0% year over year. For fiscal 2025 it was $144.78M, up 32.8% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is $153.82M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $144.78M | +32.8% |
| FY2024 | Dec 31, 2024 | $109.02M | -4.1% |
| FY2023 | Dec 31, 2023 | $113.63M | -26.1% |
| FY2022 | Dec 31, 2022 | $153.82M | +17.6% |
| FY2021 | Dec 31, 2021 | $130.84M | +9.3% |
| FY2020 | Dec 31, 2020 | $119.75M | +5.2% |
| FY2019 | Dec 31, 2019 | $113.86M | +7.2% |
| FY2018 | Dec 31, 2018 | $106.21M | +25.3% |
| FY2017 | Dec 31, 2017 | $84.77M | +44.7% |
| FY2016 | Dec 31, 2016 | $58.58M | +12.4% |
| FY2015 | Dec 31, 2015 | $52.12M | -14.6% |
| FY2014 | Dec 31, 2014 | $61.04M | -6.2% |
| FY2013 | Dec 31, 2013 | $65.05M | +15.6% |
| FY2012 | Dec 31, 2012 | $56.28M | +15.5% |
| FY2011 | Dec 31, 2011 | $48.71M | +14.9% |
| FY2010 | Dec 31, 2010 | $42.38M | +15.5% |
| FY2009 | Dec 31, 2009 | $36.69M | +12.5% |
| FY2008 | Dec 31, 2008 | $32.60M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $45.12M | +70.3% |
| Q1 FY2026 | Mar 31, 2026 | $44.39M | +75.5% |
| Q4 FY2025 | Dec 31, 2025 | $12.63M | -71.7% |
| Q3 FY2025 | Sep 28, 2025 | $57.23M | +47.8% |
| Q2 FY2025 | Jun 29, 2025 | $26.49M | -35.5% |
| Q1 FY2025 | Mar 30, 2025 | $25.30M | -32.2% |
| Q4 FY2024 | Dec 31, 2024 | $44.55M | +24.2% |
| Q3 FY2024 | Sep 29, 2024 | $38.73M | +3.1% |
| Q2 FY2024 | Jun 30, 2024 | $41.09M | +4.2% |
| Q1 FY2024 | Mar 31, 2024 | $37.30M | -10.1% |
| Q4 FY2023 | Dec 31, 2023 | $35.86M | -16.1% |
| Q3 FY2023 | Oct 1, 2023 | $37.58M | -0.5% |
| Q2 FY2023 | Jul 2, 2023 | $39.45M | +6.8% |
| Q1 FY2023 | Apr 2, 2023 | $41.47M | +14.1% |
| Q4 FY2022 | Dec 31, 2022 | $42.76M | +19.4% |
| Q3 FY2022 | Sep 25, 2022 | $37.77M | +18.7% |
| Q2 FY2022 | Jun 26, 2022 | $36.93M | +11.0% |
| Q1 FY2022 | Mar 27, 2022 | $36.36M | +21.4% |
| Q4 FY2021 | Dec 31, 2021 | $35.80M | +6.0% |
| Q3 FY2021 | Sep 26, 2021 | $31.82M | +8.9% |
| Q2 FY2021 | Jun 27, 2021 | $33.28M | +13.3% |
| Q1 FY2021 | Mar 28, 2021 | $29.95M | +9.3% |
| Q4 FY2020 | Dec 31, 2020 | $33.77M | +8.5% |
| Q3 FY2020 | Sep 27, 2020 | $29.22M | +4.4% |
| Q2 FY2020 | Jun 28, 2020 | $29.36M | +6.4% |
| Q1 FY2020 | Mar 29, 2020 | $27.40M | +0.9% |
| Q4 FY2019 | Dec 31, 2019 | $31.13M | +12.0% |
| Q3 FY2019 | Sep 29, 2019 | $27.98M | +6.1% |
| Q2 FY2019 | Jun 30, 2019 | $27.60M | +6.1% |
| Q1 FY2019 | Mar 31, 2019 | $27.15M | +4.3% |
| Q4 FY2018 | Dec 31, 2018 | $27.80M | +9.1% |
| Q3 FY2018 | Sep 30, 2018 | $26.37M | +24.4% |
| Q2 FY2018 | Jul 1, 2018 | $26.02M | +28.3% |
| Q1 FY2018 | Apr 1, 2018 | $26.03M | +46.0% |
| Q4 FY2017 | Dec 31, 2017 | $25.47M | +62.4% |
| Q3 FY2017 | Oct 1, 2017 | $21.19M | +40.7% |
| Q2 FY2017 | Jul 2, 2017 | $20.28M | – |
| Q1 FY2017 | Apr 2, 2017 | $17.83M | – |
| Q4 FY2016 | Dec 31, 2016 | $15.69M | – |
| Q3 FY2016 | Sep 25, 2016 | $15.07M | – |
See a number that looks wrong?